KHC
9
-4
ICE
59
-3
JBHT
56
-3
ISRG
71
-5
EIX
70
3
EW
32
3
NVDA
52
-5
SLB
52
-3
TGT
45
-4
NWSA
62
-7
BSX
64
-3
SYY
49
9
AXP
67
-2
FAST
57
-3
GM
74
5
MMM
35
-5
MCD
52
-5
EMR
71
-3
CINF
53
3
KLAC
38
-6
KHC
9
-4
ICE
59
-3
JBHT
56
-3
ISRG
71
-5
EIX
70
3
EW
32
3
NVDA
52
-5
SLB
52
-3
TGT
45
-4
NWSA
62
-7
BSX
64
-3
SYY
49
9
AXP
67
-2
FAST
57
-3
GM
74
5
MMM
35
-5
MCD
52
-5
EMR
71
-3
CINF
53
3
KLAC
38
-6
Financhill
Back

Baxter International Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
27

BAX
Baxter International

Last Price:
31.97
Seasonality Move:
3.58%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
27
Baxter International (BAX) is a Sell

Is Baxter International a Buy, Sell or Hold?

  • The current Baxter International [BAX] share price is $31.96. The Score for BAX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • BAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BAX Stock Price Chart

What is Baxter International's stock price today?

  • The Baxter International share price today is $31.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BAX is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.15 Sell
Relative Strength Index (14 RSI): 21.73 Sell
Chaikin Money Flow: 521490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.06 - 37.02) Sell
Bollinger Bands (100): (34.5 - 38.16) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.89 Sell
20-day SMA: 35.24 Sell
50-day SMA: 36.9 Sell
200-day SMA: 37.57 Sell
8-day EMA: 33.46 Sell
20-day EMA: 34.82 Sell
50-day EMA: 35.97 Sell
200-day EMA: 37.31 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Baxter International Earnings Growth & BAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.76 per share, and an increase next year of $0.68 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Baxter International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):